Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer
Open Access
- 17 August 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 92 (9) , 1103-1109
- https://doi.org/10.1002/bjs.4979
Abstract
Background: Extended lymphadenectomy for gastric carcinoma has been associated with high mortality and morbidity rates in several multicentre randomized trials. Methods: Using data from 523 patients registered for a prospective randomized trial comparing extended (D2) and superextended (D3) lymphadenectomies, risk factors for overall complications and major surgical complications (anastomotic leakage, intra-abdominal abscess and pancreatic fistula) were identified by multivariate logistic regression analysis. Results: Mortality and morbidity rates were 0·8 per cent (four of 523) and 24·5 per cent (128 of 523) respectively. Pancreatectomy (relative risk 5·62 (95 per cent confidence interval (c.i.) 1·94 to 16·27)) and prolonged operating time (relative risk 2·65 (95 per cent confidence interval 1·34 to 5·23)) were the most important risk factors for overall complications. A body mass index of 25 kg/m2 or above, pancreatectomy and age greater than 65 years were significant predictors of major surgical complications. Conclusion: Pancreatectomy should be reserved for patients with stage T4 disease. Age and obesity should be considered when planning surgery.Keywords
Funding Information
- Grant-in-Aid for Cancer Research from the Ministry of Health and Welfare and the Second Term Comprehensive 10-year Strategy for Cancer Control by the Ministry of Health and Welfare, Japan
This publication has 20 references indexed in Scilit:
- Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501Journal of Clinical Oncology, 2004
- Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)Journal of Clinical Oncology, 2003
- Extended Lymph Node Dissection in Gastric CarcinomaJournal of the American College of Surgeons, 2002
- Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma – a population-based study in SwedenBritish Journal of Cancer, 2000
- Estimates of the worldwide mortality from 25 cancers in 1990International Journal of Cancer, 1999
- A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomySurgery, 1999
- Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trialBritish Journal of Cancer, 1999
- Japanese Classification of Gastric Carcinoma – 2nd English Edition –Gastric Cancer, 1998
- The national cancer data base report on gastric carcinomaCancer, 1997
- Early results of extended total gastrectomy for cancerCancer, 1956